FDA Removes Black Box Warning on Menopause Hormone Therapy
TL;DR
The FDA has removed the 'black box' warning on hormone replacement therapy for menopause, citing new research that shows the treatments are safer than previously thought, which may increase their use among women and doctors. The agency will still warn about endometrial cancer risk and has approved two new menopause-related drugs. This change follows a reevaluation of past studies linking hormone therapy to serious health risks, and reflects a broader shift in conversations about women's health during midlife.
- "Black box" warning from menopause hormone therapy scrapped by FDA Axios
- F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause The New York Times
- HHS Secretary Kennedy News Conference on Women's Health C-SPAN
- Hormone replacement therapy will no longer carry a warning label, FDA says NBC News
- Opinion | Marty Makary: The FDA Liberates Women’s Hormone Replacement Therapy The Wall Street Journal
Want the full story? Read the original reporting
Read on Axios